13 / 2024
Professor Stefan Vieths will become the new president of the Paul-Ehrlich-Institut on 1 January 2025. Federal Minister of Health Professor Karl Lauterbach officially presented the certificate of appointment to the new president in Berlin on 20 December 2024. Stefan Vieths has been working at the Paul-Ehrlich-Institut since 1995 and has been acting head of the Institute since the beginning of 2024. Prior to this, he held the office of vice president for 13 years. With his appointment as president, he continues his duties as manager, regulator and researcher at the helm of the Paul-Ehrlich-Institut. Stefan Vieths knows the Institute and its specialisations very well. He will drive the further development of the Paul-Ehrlich-Institut to continue to position it as the leading medicines authority in the field of biomedicines in the future.
Source: BMG/Thomas Ecke
Stefan Vieths is a state-certified food chemist and professor (außerplanmäßiger Professor) at the faculty of biochemistry, chemistry and pharmacy at the Goethe University Frankfurt/Main, Germany. As an internationally renowned scientist with many years of leadership experience at the Paul-Ehrlich-Institut and as a designated expert at the European Medicines Agency (EMA) and the European Pharmacopoeia Commission, he has played a key role in shaping current international medicinal product regulations and was in charge of implementing the reorganisation of the Institute, which was completed in 2024. Through his scientific commitment and regulatory expertise, Stefan Vieths has been making key contributions to the further development and cultivation of quality, safety and efficacy in biomedicines in the field of allergology for more than three decades.
Federal Minister of Health Professor Karl Lauterbach:
"With Stefan Vieths as president the Paul-Ehrlich-Institut will once again be headed by an experienced and renowned scientist. The Paul-Ehrlich-Institut plays a decisive role in the promotion of research and the development of new medicines. This is where Professor Vieths' international experience in European medicinal product authorisation issues will be particularly useful."
Professor Stefan Vieths, President of the Paul-Ehrlich-Institut:
"I look forward to continue the professional and organisational development of the Paul-Ehrlich-Institut and to further strengthen its importance as a specialised and internationally relevant authority in the field of biomedicines. This also includes actively implementing the Medical Research Act that has come into force by integrating our work into the context of a more efficient, digitalised, and harmonised system. For us at the Paul-Ehrlich-Institut, research, testing, evaluation, authorisation, and the monitoring of biomedicines go hand in hand. We will continue to use the flexibility and adaptability of our Institute to create new structures to meet the challenges of the future."
Updated: 20.12.2024
